Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Portha

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Diabetologia|May 27, 2017
HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cellsIndri Purwana, Jun J Liu, Bernard Portha, et al.
Frontiers in Endocrinology|November 28, 2022
Editorial: Understanding the gene expression of β cell dysfunction in diabetesÅke Sjöholm, John A Corbett, Po Sing Leung, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2009
Diabetic GK/Par rat beta-cells are spontaneously protected against H2O2-triggered apoptosis. A cAMP-dependent adaptive responseGrégory Lacraz, Florence Figeac, Jamileh Movassat, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Local in vivo GSK3β knockdown promotes pancreatic β cell and acinar cell regeneration in 90% pancreatectomized ratFlorence Figeac, Anissa Ilias, Danielle Bailbe, et al.
Journal of Diabetes Research|June 14, 2013
The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazoneDanielle Bailbé, Erwann Philippe, Evgeniy Gorbunov, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic ratsFlorence Figeac, Benjamin Uzan, Monique Faro, et al.
Pancreas|November 3, 2006
Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling periodSophie Calderari, Marie-Noëlle Gangnerau, Marie-José Meile, et al.
Diabetes|April 30, 2002
Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4Cécile Tourrel, Danielle Bailbe, Matthieu Lacorne, et al.
International Journal of Molecular Medicine|March 14, 2002
Metabolism of D-[3-3H]glucose, D-[5-3H]glucose, D-[U-14C]glucose, D-[1-14C]glucose and D-[6-14C]glucose in pancreatic islets in an animal model of type-2 diabetesMarie-Helene Giroix, Abdellatif Bakkali Nadi, Abdullah Sener, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
The GK rat: a prototype for the study of non-overweight type 2 diabetesBernard Portha, Marie-Hélène Giroix, Cecile Tourrel-Cuzin, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Diabetologia|May 27, 2017
HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cellsIndri Purwana, Jun J Liu, Bernard Portha, et al.
Frontiers in Endocrinology|November 28, 2022
Editorial: Understanding the gene expression of β cell dysfunction in diabetesÅke Sjöholm, John A Corbett, Po Sing Leung, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 22, 2009
Diabetic GK/Par rat beta-cells are spontaneously protected against H2O2-triggered apoptosis. A cAMP-dependent adaptive responseGrégory Lacraz, Florence Figeac, Jamileh Movassat, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Local in vivo GSK3β knockdown promotes pancreatic β cell and acinar cell regeneration in 90% pancreatectomized ratFlorence Figeac, Anissa Ilias, Danielle Bailbe, et al.
Journal of Diabetes Research|June 14, 2013
The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazoneDanielle Bailbé, Erwann Philippe, Evgeniy Gorbunov, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 19, 2009
Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic ratsFlorence Figeac, Benjamin Uzan, Monique Faro, et al.
Pancreas|November 3, 2006
Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling periodSophie Calderari, Marie-Noëlle Gangnerau, Marie-José Meile, et al.
Diabetes|April 30, 2002
Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4Cécile Tourrel, Danielle Bailbe, Matthieu Lacorne, et al.
International Journal of Molecular Medicine|March 14, 2002
Metabolism of D-[3-3H]glucose, D-[5-3H]glucose, D-[U-14C]glucose, D-[1-14C]glucose and D-[6-14C]glucose in pancreatic islets in an animal model of type-2 diabetesMarie-Helene Giroix, Abdellatif Bakkali Nadi, Abdullah Sener, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
The GK rat: a prototype for the study of non-overweight type 2 diabetesBernard Portha, Marie-Hélène Giroix, Cecile Tourrel-Cuzin, et al.
Pageof 6